9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Institut Bergonié
Esperas Pharma Inc.
IGM Biosciences, Inc.
Immodulon Therapeutics Ltd
Taiho Pharmaceutical Co., Ltd.
ImmunityBio, Inc.
University of Pittsburgh
UNICANCER
Altor BioScience